Serum concentrations of eosinophil cationic protein and eosinophils of patients with Kimura's disease

Allergology International

Volumn 56, Issue 1, 2007, Pages 45-49

  Ohta, Nobuo ^a   Okazaki, Shinichi ^a   Fukase, Shigeru ^a   Akatsuka, Naoko ^a   Aoyagi, Masaru ^a   Yamakawa, Mitsunori ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

EG 2; Eosinophil cationic protein; Eosinophils; Kimura's disease

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; INTERLEUKIN 5;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KIMURA DISEASE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS;

EID: 33947387970     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.O-06-442     Document Type: Article

References (16)

1. Kimura T, Yoshimura S, Ishikawa E. On the unusual granulation combined with hyperplastic changes of lymphoid tissue. Trans. Soc. Pathol. Jpn. 1948;37:179-190.
2. Wells GC, Summerly R. Subcutaneous lymphoid hyperplasia with eosinophilia. Proc. R. Soc. Med. 1963;56:728-735.
3. Iizuka S. Eosinophilic lymphadenitis and eosinophilic lymphoid granuloma: A proposal of a new concept on disease of the lymph node and its surrounding tissue. Nihon. Univ. Med. J. 1959;18:900-908.
4. Terada N, Konno A, Shiratori K et al. Mechanism of eosinophil infiltration in the patient with subcutaneous angioblastic lymphoid hyperplasia with eosinophilia (Kimura's disease). Int. Arch. Allergy Immunol. 1994;104 (Suppl):18-20.
5. Hirashima M, Tshiro K, Sakata K, Muramoto K, Iyama K. Eosinophil chemotoctic factors from granuloma of Kimura's disease, with special reference to T lymphocyte-derived factors. J. Leukoc. Biol. 1986;40:393-405.
6. Motojima S, Frigas E, Loegering DA et al. Toxicity of eosinophil cationic protein for guinea pig tracheal epithelium in vitro. Am. Rev. Respir. Dis. 1989;139:801-805.
7. Venge P, Dahl R, Freden K et al. Epithelial injury by human eosinophil. Am. Rev. Respir. Dis. 1988;138:554-557.
8. Zheutlin LM, Ackerman SJ, Gleich GJ et al. Stimulation of basophil and rat mast cell histamine release by eosinophil granule derived cationic protein. J. Immunol. 1984;133:2180-2185.
9. Bousquet J, Chanez P, Lacoste JY et al. Eosinophilic inflammation in asthma. New Eng. J. Med. 1990;324:1033-1039.
10. Beppu T, Ohta N, Gonn S et al. Eosinophil and eosinophil cationic protein in allergic rhinitis. Acta Otolaryngol. 1994;511 (Suppl):221-223.
11. Bhandari CM, Baldwa VS. Relative value of peripheral blood, secretion and Tissue eosinophilia in the diagnosis of different patterns of allergic rhinitis. Ann. Allergy 1997;37:280-284.
12. Morita H, Kitano Y. Kimura's disease with high serum levels of eosinohill cationic protein and major basic protein. Clin. Immunol. Immunopathol. 1994;72:280-281.
13. Kimura Y, Pawankar R, Aoki M et al. Mast cells and T cells in Kimura's disease express increased levels of IL-4, IL-5, eotaxin and RANTES. Clin. Exp. Allergy 2002;32:1787-1793.
14. Tsukadaira A, Kitano K, Okubo Y et al. A case of pathophysiologic study in Kimura's disease. Measurement of cytokines and surface analysis of eosinophils. Ann. Allergy Asthma Immunol. 1998;81:423-427.
15. Koike T, Enokihara H, Ariumi H et al. Serum concentration of IL-5, GM-CSF, and IL-3 and the production by lymphocytes in various eosinophilia. Am. J. Hematol. 1995;50:98-102.
16. Motojima S, Tateishi K, Koseki T et al. Serum levels of eosinophil cationic protein and IL-5 in patients with asthma without systemic corticosteroids. Int. Arch. Allergy Immunol. 1997;114:55-59.